Symbol
| KCNAB2
| contributors: shn - updated : 28-02-2024
|
HGNC name
| potassium voltage-gated channel, shaker-related subfamily, beta member 2
|
HGNC id
| 6229
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
|  
| loss of function
|
can contribute to the Brugada electrocardiographic pattern | |
Susceptibility
|
to epilepsia |
Variant & Polymorphism
|
| |
Candidate gene
| for seizures in del1p36 syndrome, primary gene or modifier |
Marker
| can be exploited as a predictive biomarker for evaluating prognosis in Lung adenocarcinoma (LUAD) |
Therapy target
|
System | Type | Disorder | Pubmed |
tumor | | | |
potential new target and pharmacological candidate to be considered in the development of clinical therapeutics for acromegaly | cancer | lung | | |
possible immunotherapeutic target in Lung adenocarcinoma (LUAD) |
| |
| Kvbeta2-null mice have reduced life spans, occasional seizures, and cold swim-induced tremors ( | |
mice deleted for KCNAB2 leads to deficits in associative learning and memory, a reduction in the slow afterhyperpolarization following a burst of action potentials and a concomitant increase in neuronal excitability in projection neurons in the lateral nucleus of the amygdala ( |